HIV pre-exposure prophylaxis for women and infants prevents vaginal and oral HIV transmission in a preclinical model of HIV infection.
about
Predicting HIV Pre-exposure Prophylaxis Efficacy for Women using a Preclinical Pharmacokinetic-Pharmacodynamic In Vivo Model.A Review of HIV Pre-Exposure Prophylaxis: The Female PerspectiveM184I/V substitutions and E138K/M184I/V double substitutions in HIV reverse transcriptase do not significantly affect the antiviral activity of EFdA.
P2860
HIV pre-exposure prophylaxis for women and infants prevents vaginal and oral HIV transmission in a preclinical model of HIV infection.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
HIV pre-exposure prophylaxis f ...... inical model of HIV infection.
@en
HIV pre-exposure prophylaxis f ...... inical model of HIV infection.
@nl
type
label
HIV pre-exposure prophylaxis f ...... inical model of HIV infection.
@en
HIV pre-exposure prophylaxis f ...... inical model of HIV infection.
@nl
prefLabel
HIV pre-exposure prophylaxis f ...... inical model of HIV infection.
@en
HIV pre-exposure prophylaxis f ...... inical model of HIV infection.
@nl
P2093
P2860
P356
P1476
HIV pre-exposure prophylaxis f ...... inical model of HIV infection.
@en
P2093
Angela Wahl
Caroline E Baker
Chandrav De
Christopher C Nixon
J Victor Garcia
Rae Ann Spagnuolo
Uma Shanmugasundaram
P2860
P304
P356
10.1093/JAC/DKW283
P407
P577
2016-08-01T00:00:00Z